Antioxidant N-Acetylcysteine Attenuates the Reduction of Brg1 Protein Expression in the Myocardium of Type 1 Diabetic Rats
Figure 1
Effects of N-acetylcysteine (NAC) treatment on the level of TNF-alpha (a) and IL-6 (b) in plasma. Control (C) or STZ-induced diabetic rats without treatment (D) or with NAC treatment (1.5 g/kg/day, D + NAC) for 4 weeks. All values are expressed as mean ± S.E.M. per group. versus C; versus D.
